KYMERA THERAPEUTICS INC (KYMR) Forecast, Price Target & Analyst Ratings

NASDAQ:KYMR • US5015751044

Current stock price

83.29 USD
+3.81 (+4.79%)
At close:
83.29 USD
0 (0%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KYMERA THERAPEUTICS INC (KYMR).

Forecast Snapshot

Consensus Price Target

Price Target
$121.23
+ 45.55% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.90
Revenue Estimate
8.529M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.21%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$121.23
Upside
+ 45.55%
From current price of $83.29 to mean target of $121.23, Based on 29 analyst forecasts
Low
$91.91
Median
$121.38
High
$147.00

Price Target Revisions

1 Month
5.62%
3 Months
8.45%

Price Target Summary

29 Wall Street analysts provided a forecast for the next 12 months for KYMR. The average price target is 121.23 USD. This implies a price increase of 45.55% is expected in the next year compared to the current price of 83.29.
The average price target has been revised upward by 8.45% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

KYMR Current Analyst RatingKYMR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

KYMR Historical Analyst RatingsKYMR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
86.21%
KYMR was analyzed by 29 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about KYMR.
In the previous month the buy percentage consensus was at a similar level.
KYMR was analyzed by 29 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-03UBSMaintains Buy -> Buy
2026-03-02Stephens & Co.Maintains Overweight -> Overweight
2026-03-02CitigroupMaintains Buy -> Buy
2026-02-26BTIGMaintains Buy -> Buy
2026-02-26Piper SandlerMaintains Overweight -> Overweight
2026-02-03BTIGReiterate Buy -> Buy
2026-01-28BarclaysMaintains Overweight -> Overweight
2026-01-15BTIGReiterate Buy -> Buy
2026-01-06Wolfe ResearchDowngrade Outperform -> Peer Perform
2025-12-22B. Riley SecuritiesMaintains Buy -> Buy
2025-12-16RBC CapitalMaintains Outperform -> Outperform
2025-12-11MizuhoMaintains Outperform -> Outperform
2025-12-11Stephens & Co.Maintains Overweight -> Overweight
2025-12-10JP MorganMaintains Overweight -> Overweight
2025-12-09Leerink PartnersMaintains Outperform -> Outperform
2025-12-09BTIGMaintains Buy -> Buy
2025-12-09OppenheimerMaintains Outperform -> Outperform
2025-12-09BarclaysMaintains Overweight -> Overweight
2025-12-09Wells FargoMaintains Overweight -> Overweight
2025-12-09Truist SecuritiesMaintains Buy -> Buy
2025-12-09B of A SecuritiesMaintains Buy -> Buy
2025-12-09Morgan StanleyMaintains Overweight -> Overweight
2025-12-09Piper SandlerReiterate Overweight -> Overweight
2025-12-09CitigroupMaintains Buy -> Buy
2025-12-09JefferiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.90
Revenue Estimate
8.529M
Revenue Q2Q
-61.41%
EPS Q2Q
-9.67%
Number of Analysts
23

Next Earnings Revisions

Revenue (1 Month)
-18.82%
Revenue (3 Months)
-16.51%
EPS (1 Month)
-4.08%
EPS (3 Months)
6.95%

Next Earnings Summary

KYMR is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.9 USD and the consensus revenue estimate is 8.53M USD.
The next earnings revenue estimate has been revised downward by 16.51% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
KYMR revenue by date.KYMR revenue by date.
78.592M
67.82%		47.072M
-40.11%		39.211M
-16.70%		43.857M
11.85%		47.272M
7.79%		41.183M
-12.88%		49.774M
20.86%		122.83M
146.78%		382.25M
211.20%		3.209B
739.50%		6.31B
96.63%
EBITDA
YoY % growth
KYMR ebitda by date.KYMR ebitda by date.
-161.965M
-2.33%		-249.337M
-53.94%		-337.231M
-35.25%		-354.656M
-5.17%		-396.547M
-11.81%		-401.107M
-1.15%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
KYMR ebit by date.KYMR ebit by date.
-165.53M
-2.65%		-256.71M
-55.08%		-345.544M
-34.60%		-395.971M
-14.59%		-444.135M
-12.16%		-488.58M
-10.01%		-510.187M
-4.42%		-562.203M
-10.20%		-429.303M
23.64%		1.393B
424.48%		2.884B
107.04%
Operating Margin
KYMR operating margin by date.KYMR operating margin by date.
-210.62%-545.36%-881.24%-902.87%-939.53%-1,186.36%-1,025.01%-457.71%-112.31%43.41%45.71%
EPS
YoY % growth
KYMR eps by date.KYMR eps by date.
-2.52
12.50%		-2.90
-15.08%		-3.68
-26.90%		-3.78
-2.70%		-4.25
-12.38%		-4.61
-8.58%		-4.20
8.88%		-4.58
-9.01%		-3.49
23.85%		12.42
456.08%		25.43
104.70%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.90
-9.67%		-0.95
0.18%		-0.97
-2.85%		-0.98
-1.02%		-1.05
-16.83%		-1.01
-6.49%		-1.02
-5.51%		-1.03
-5.13%
Revenue
Q2Q % growth		8.529M
-61.41%		8.512M
-25.83%		11.046M
299.64%		11.664M
306.27%		17.85M
109.29%		15.3M
79.75%		15.3M
38.51%		15.3M
31.17%
EBITDA
Q2Q % growth		-97.433M
-34.62%		-98.651M
-22.66%		-87.366M
-6.05%		-94.884M
-5.92%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-96.915M
-30.22%		-99.249M
-17.38%		-99.477M
-12.19%		-102.93M
-5.14%		-96.798M
0.12%		-100.776M
-1.54%		-102.204M
-2.74%		-103.734M
-0.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

KYMR Yearly Revenue VS EstimatesKYMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
KYMR Yearly EPS VS EstimatesKYMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-7.81%
EPS Next 5 Year
-4.48%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-9.98%
Revenue Next 5 Year
16.82%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-6.45%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KYMERA THERAPEUTICS INC / KYMR Forecast FAQ

Can you provide the average price target for KYMERA THERAPEUTICS INC stock?

29 analysts have analysed KYMR and the average price target is 121.23 USD. This implies a price increase of 45.55% is expected in the next year compared to the current price of 83.29.

When does KYMERA THERAPEUTICS INC (KYMR) report earnings?

KYMERA THERAPEUTICS INC (KYMR) will report earnings on 2026-05-07.

What are the consensus estimates for KYMR stock next earnings?

The consensus EPS estimate for the next earnings of KYMERA THERAPEUTICS INC (KYMR) is -0.9 USD and the consensus revenue estimate is 8.53M USD.

What is the consensus rating for KYMERA THERAPEUTICS INC (KYMR) stock?

The consensus rating for KYMERA THERAPEUTICS INC (KYMR) is 86.2069 / 100 . This indicates that analysts generally have a positive outlook on the stock.